Vanguard Group’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.1M Buy
5,106,867
+204,621
+4% +$1.89M ﹤0.01% 2147
2025
Q1
$42.1M Buy
4,902,246
+221,802
+5% +$1.9M ﹤0.01% 2162
2024
Q4
$50.3M Sell
4,680,444
-59,727
-1% -$641K ﹤0.01% 2157
2024
Q3
$26.9M Buy
4,740,171
+191,952
+4% +$1.09M ﹤0.01% 2449
2024
Q2
$19.2M Buy
4,548,219
+133,537
+3% +$564K ﹤0.01% 2595
2024
Q1
$22.5M Buy
4,414,682
+54,034
+1% +$275K ﹤0.01% 2545
2023
Q4
$40.6M Buy
4,360,648
+115,304
+3% +$1.07M ﹤0.01% 2276
2023
Q3
$27.8M Buy
4,245,344
+41,193
+1% +$270K ﹤0.01% 2406
2023
Q2
$34.2M Buy
4,204,151
+33,547
+0.8% +$273K ﹤0.01% 2359
2023
Q1
$35.7M Buy
4,170,604
+26,104
+0.6% +$224K ﹤0.01% 2329
2022
Q4
$38.4M Buy
4,144,500
+38,505
+0.9% +$357K ﹤0.01% 2317
2022
Q3
$42.4M Buy
4,105,995
+119,684
+3% +$1.24M ﹤0.01% 2267
2022
Q2
$39.9M Buy
3,986,311
+101,870
+3% +$1.02M ﹤0.01% 2298
2022
Q1
$47.8M Buy
3,884,441
+42,871
+1% +$528K ﹤0.01% 2329
2021
Q4
$66.6M Sell
3,841,570
-149,802
-4% -$2.6M ﹤0.01% 2194
2021
Q3
$71.6M Buy
3,991,372
+343,379
+9% +$6.16M ﹤0.01% 2168
2021
Q2
$83.4M Buy
3,647,993
+254,335
+7% +$5.81M ﹤0.01% 2089
2021
Q1
$50.7M Buy
3,393,658
+496,767
+17% +$7.43M ﹤0.01% 2307
2020
Q4
$15.6M Buy
2,896,891
+133,009
+5% +$718K ﹤0.01% 2760
2020
Q3
$12.6M Buy
2,763,882
+240,693
+10% +$1.1M ﹤0.01% 2675
2020
Q2
$12.4M Buy
2,523,189
+62,806
+3% +$309K ﹤0.01% 2659
2020
Q1
$7.75M Buy
2,460,383
+25,792
+1% +$81.2K ﹤0.01% 2736
2019
Q4
$6.31M Sell
2,434,591
-4,889
-0.2% -$12.7K ﹤0.01% 3087
2019
Q3
$7.71M Buy
2,439,480
+448,806
+23% +$1.42M ﹤0.01% 2955
2019
Q2
$6.71M Buy
1,990,674
+1,178,831
+145% +$3.97M ﹤0.01% 3063
2019
Q1
$2.48M Buy
811,843
+171,389
+27% +$523K ﹤0.01% 3381
2018
Q4
$999K Sell
640,454
-1,016,685
-61% -$1.59M ﹤0.01% 3566
2018
Q3
$4.52M Sell
1,657,139
-35,000
-2% -$95.6K ﹤0.01% 3274
2018
Q2
$4.43M Sell
1,692,139
-77,288
-4% -$202K ﹤0.01% 3250
2018
Q1
$4.88M Buy
1,769,427
+35,352
+2% +$97.6K ﹤0.01% 3165
2017
Q4
$5.58M Buy
1,734,075
+77,560
+5% +$250K ﹤0.01% 3089
2017
Q3
$6.86M Buy
1,656,515
+38,758
+2% +$160K ﹤0.01% 2988
2017
Q2
$8.61M Buy
1,617,757
+132,076
+9% +$703K ﹤0.01% 2852
2017
Q1
$8.53M Buy
1,485,681
+171,577
+13% +$985K ﹤0.01% 2829
2016
Q4
$5.2M Buy
1,314,104
+114,943
+10% +$455K ﹤0.01% 3048
2016
Q3
$4.35M Buy
1,199,161
+30,148
+3% +$109K ﹤0.01% 3074
2016
Q2
$7.14M Buy
1,169,013
+164,686
+16% +$1.01M ﹤0.01% 2806
2016
Q1
$4.92M Buy
1,004,327
+543,507
+118% +$2.66M ﹤0.01% 2963
2015
Q4
$2.57M Buy
+460,820
New +$2.57M ﹤0.01% 3293